{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T23:38:08Z","timestamp":1793403488020,"version":"4.5.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T00:00:00Z","timestamp":1655078400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T00:00:00Z","timestamp":1655078400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"crossref","award":["AA\/18\/7\/34219"],"award-info":[{"award-number":["AA\/18\/7\/34219"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MC_UU_00011\/1, MC_UU_00011\/4, MC_UU_00011\/6 and MC_UU_00011\/7"],"award-info":[{"award-number":["MC_UU_00011\/1, MC_UU_00011\/4, MC_UU_00011\/6 and MC_UU_00011\/7"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/P014054\/1"],"award-info":[{"award-number":["MR\/P014054\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"crossref","award":["C52724\/A20138 & C18281\/A29019"],"award-info":[{"award-number":["C52724\/A20138 & C18281\/A29019"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Vice-Chancellor Fellowship"},{"name":"Academy of Medical Sciences (AMS) Springboard Award, the Wellcome Trust, the Government Department of Business, Energy and Industrial Strategy (BEIS), the British Heart Foundation and Diabetes UK","award":["SBF006\\1117"],"award-info":[{"award-number":["SBF006\\1117"]}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["208806\/Z\/17\/Z"],"award-info":[{"award-number":["208806\/Z\/17\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["FS\/18\/23\/33512"],"award-info":[{"award-number":["FS\/18\/23\/33512"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Institute for Health Research Oxford Biomedical Research Centre"},{"name":"National Institute for Health Research (NIHR) Biomedical Research Centre based at University Hospitals Bristol NHS Foundation and the University of Bristol"},{"DOI":"10.13039\/501100000272","name":"National Institute of Health Research","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["CH\/F\/20\/90003"],"award-info":[{"award-number":["CH\/F\/20\/90003"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Institute of Health Research Senior Investigator","award":["NF-0616-10102"],"award-info":[{"award-number":["NF-0616-10102"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Despite early interest in the health effects of polyunsaturated fatty acids (PUFA), there is still substantial controversy and uncertainty on the evidence linking PUFA to cardiovascular diseases (CVDs). We investigated the effect of plasma concentration of omega-3 PUFA (i.e. docosahexaenoic acid (DHA) and total omega-3 PUFA) and omega-6 PUFA (i.e. linoleic acid and total omega-6 PUFA) on the risk of CVDs using Mendelian randomization.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We conducted the largest genome-wide association study (GWAS) of circulating PUFA to date including a sample of 114,999 individuals and incorporated these data in a two-sample Mendelian randomization framework to investigate the involvement of circulating PUFA on a wide range of CVDs in up to 1,153,768 individuals of European ancestry (i.e. coronary artery disease, ischemic stroke, haemorrhagic stroke, heart failure, atrial fibrillation, peripheral arterial disease, aortic aneurysm, venous thromboembolism and aortic valve stenosis).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>GWAS identified between 46 and 64 SNPs for the four PUFA traits, explaining 4.8\u20137.9% of circulating PUFA variance and with mean F statistics &gt;100. Higher genetically predicted DHA (and total omega-3 fatty acids) concentration was related to higher risk of some cardiovascular endpoints; however, these findings did not pass our criteria for multiple testing correction and were attenuated when accounting for LDL-cholesterol through multivariable Mendelian randomization or excluding SNPs in the vicinity of the <jats:italic>FADS<\/jats:italic> locus. Estimates for the relation between higher genetically predicted linoleic acid (and total omega-6) concentration were inconsistent across different cardiovascular endpoints and Mendelian randomization methods. There was weak evidence of higher genetically predicted linoleic acid being related to lower risk of ischemic stroke and peripheral artery disease when accounting by LDL-cholesterol.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>We have conducted the largest GWAS of circulating PUFA to date and the most comprehensive Mendelian randomization analyses. Overall, our Mendelian randomization findings do not support a protective role of circulating PUFA concentration on the risk of CVDs. However, horizontal pleiotropy via lipoprotein-related traits could be a key source of bias in our analyses.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12916-022-02399-w","type":"journal-article","created":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T00:02:25Z","timestamp":1655078545000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":178,"title":["Role of circulating polyunsaturated fatty acids on cardiovascular diseases risk: analysis using Mendelian randomization and fatty acid genetic association data from over 114,000 UK Biobank participants"],"prefix":"10.1186","volume":"20","author":[{"given":"Maria Carolina","family":"Borges","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip C.","family":"Haycock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gibran","family":"Hemani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael V.","family":"Holmes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Davey Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aroon D.","family":"Hingorani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah A.","family":"Lawlor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,13]]},"reference":[{"issue":"12","key":"2399_CR1","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1093\/ajcn\/33.12.2657","volume":"33","author":"HO Bang","year":"1980","unstructured":"Bang HO, Dyerberg J, Sinclair HM. The composition of the Eskimo food in north western Greenland. Am J Clin Nutr. 1980;33(12):2657\u201361.","journal-title":"Am J Clin Nutr"},{"issue":"4","key":"2399_CR2","doi-asserted-by":"publisher","first-page":"441","DOI":"10.3177\/jnsv.28.441","volume":"28","author":"Y Kagawa","year":"1982","unstructured":"Kagawa Y, Nishizawa M, Suzuki M, Miyatake T, Hamamoto T, Goto K, et al. Eicosapolyenoic acids of serum lipids of Japanese islanders with low incidence of cardiovascular diseases. J Nutr Sci Vitaminol (Tokyo). 1982;28(4):441\u201353.","journal-title":"J Nutr Sci Vitaminol (Tokyo)"},{"issue":"5","key":"2399_CR3","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1093\/ajcn\/77.5.1146","volume":"77","author":"RP Mensink","year":"2003","unstructured":"Mensink RP, Zock PL, Kester AD, Katan MB. Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am J Clin Nutr. 2003;77(5):1146\u201355.","journal-title":"Am J Clin Nutr"},{"key":"2399_CR4","doi-asserted-by":"crossref","unstructured":"Abdelhamid AS, Martin N, Bridges C, Brainard JS, Wang X, Brown TJ, et al. Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease. Cochrane Database Syst Rev. 2018;11(11):CD012345.","DOI":"10.1002\/14651858.CD012345.pub2"},{"key":"2399_CR5","doi-asserted-by":"crossref","unstructured":"Hooper L, Al-Khudairy L, Abdelhamid AS, Rees K, Brainard JS, Brown TJ, et al. Omega-6 fats for the primary and secondary prevention of cardiovascular disease. Cochrane Database Syst Rev. 2018;11(11):CD011094.","DOI":"10.1002\/14651858.CD011094.pub4"},{"key":"2399_CR6","doi-asserted-by":"crossref","unstructured":"Abdelhamid AS, Brown TJ, Brainard JS, Biswas P, Thorpe GC, Moore HJ, et al. Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease. Cochrane Database Syst Rev. 2020;3(3):CD003177.","DOI":"10.1002\/14651858.CD003177.pub5"},{"issue":"3","key":"2399_CR7","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.plipres.2006.01.004","volume":"45","author":"A Jakobsson","year":"2006","unstructured":"Jakobsson A, Westerberg R, Jacobsson A. Fatty acid elongases in mammals: their regulation and roles in metabolism. Prog Lipid Res. 2006;45(3):237\u201349.","journal-title":"Prog Lipid Res"},{"issue":"7","key":"2399_CR8","doi-asserted-by":"publisher","first-page":"e1002193","DOI":"10.1371\/journal.pgen.1002193","volume":"7","author":"RN Lemaitre","year":"2011","unstructured":"Lemaitre RN, Tanaka T, Tang W, Manichaikul A, Foy M, Kabagambe EK, et al. Genetic loci associated with plasma phospholipid n-3 fatty acids: a meta-analysis of genome-wide association studies from the CHARGE Consortium. PLoS Genet. 2011;7(7):e1002193.","journal-title":"PLoS Genet"},{"issue":"3","key":"2399_CR9","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1161\/CIRCGENETICS.113.000208","volume":"7","author":"W Guan","year":"2014","unstructured":"Guan W, Steffen BT, Lemaitre RN, Wu JH, Tanaka T, Manichaikul A, et al. Genome-wide association study of plasma N6 polyunsaturated fatty acids within the cohorts for heart and aging research in genomic epidemiology consortium. Circ Cardiovasc Genet. 2014;7(3):321\u201331.","journal-title":"Circ Cardiovasc Genet"},{"issue":"2","key":"2399_CR10","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1161\/CIRCGENETICS.112.964619","volume":"6","author":"JH Wu","year":"2013","unstructured":"Wu JH, Lemaitre RN, Manichaikul A, Guan W, Tanaka T, Foy M, et al. Genome-wide association study identifies novel loci associated with concentrations of four plasma phospholipid fatty acids in the de novo lipogenesis pathway: results from the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) consortium. Circ Cardiovasc Genet. 2013;6(2):171\u201383.","journal-title":"Circ Cardiovasc Genet"},{"issue":"6","key":"2399_CR11","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/ng.2982","volume":"46","author":"SY Shin","year":"2014","unstructured":"Shin SY, Fauman EB, Petersen AK, Krumsiek J, Santos R, Huang J, et al. An atlas of genetic influences on human blood metabolites. Nat Genet. 2014;46(6):543\u201350.","journal-title":"Nat Genet"},{"key":"2399_CR12","doi-asserted-by":"publisher","first-page":"11122","DOI":"10.1038\/ncomms11122","volume":"7","author":"J Kettunen","year":"2016","unstructured":"Kettunen J, Demirkan A, Wurtz P, Draisma HH, Haller T, Rawal R, et al. Genome-wide study for circulating metabolites identifies 62 loci and reveals novel systemic effects of LPA. Nat Commun. 2016;7:11122.","journal-title":"Nat Commun"},{"key":"2399_CR13","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.plefa.2014.11.007","volume":"94","author":"NL Tintle","year":"2015","unstructured":"Tintle NL, Pottala JV, Lacey S, Ramachandran V, Westra J, Rogers A, et al. A genome-wide association study of saturated, mono- and polyunsaturated red blood cell fatty acids in the Framingham Heart Offspring Study. Prostaglandins Leukot Essent Fatty Acids. 2015;94:65\u201372.","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"1","key":"2399_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ije\/dyg070","volume":"32","author":"GD Smith","year":"2003","unstructured":"Smith GD, Ebrahim S. 'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol. 2003;32(1):1\u201322.","journal-title":"Int J Epidemiol"},{"issue":"1","key":"2399_CR15","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00439-007-0448-6","volume":"123","author":"S Ebrahim","year":"2008","unstructured":"Ebrahim S, Davey Smith G. Mendelian randomization: can genetic epidemiology help redress the failures of observational epidemiology? Hum Genet. 2008;123(1):15\u201333.","journal-title":"Hum Genet"},{"issue":"9501","key":"2399_CR16","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1016\/S0140-6736(05)67767-7","volume":"366","author":"A Hingorani","year":"2005","unstructured":"Hingorani A, Humphries S. Nature's randomised trials. Lancet. 2005;366(9501):1906\u20138.","journal-title":"Lancet"},{"issue":"12","key":"2399_CR17","doi-asserted-by":"publisher","first-page":"e352","DOI":"10.1371\/journal.pmed.0040352","volume":"4","author":"GD Smith","year":"2007","unstructured":"Smith GD, Lawlor DA, Harbord R, Timpson N, Day I, Ebrahim S. Clustered environments and randomized genes: a fundamental distinction between conventional and genetic epidemiology. PLoS Med. 2007;4(12):e352.","journal-title":"PLoS Med"},{"issue":"R1","key":"2399_CR18","doi-asserted-by":"publisher","first-page":"R89","DOI":"10.1093\/hmg\/ddu328","volume":"23","author":"G Davey Smith","year":"2014","unstructured":"Davey Smith G, Hemani G. Mendelian randomization: genetic anchors for causal inference in epidemiological studies. Hum Mol Genet. 2014;23(R1):R89\u201398.","journal-title":"Hum Mol Genet"},{"issue":"8","key":"2399_CR19","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.3390\/nu12082261","volume":"12","author":"S J\u00e4ger","year":"2020","unstructured":"J\u00e4ger S, Cuadrat R, Hoffmann P, Wittenbecher C, Schulze MB. Desaturase activity and the risk of type 2 diabetes and coronary artery disease: a Mendelian randomization study. Nutrients. 2020;12(8):2261.","journal-title":"Nutrients."},{"issue":"2","key":"2399_CR20","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.numecd.2019.09.013","volume":"30","author":"LZ Liao","year":"2020","unstructured":"Liao LZ, Li WD, Liu Y, Li JP, Zhuang XD, Liao XX. Exploring the causal pathway from omega-6 levels to coronary heart disease: a network Mendelian randomization study. Nutr Metab Cardiovasc Dis. 2020;30(2):233\u201340.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"1","key":"2399_CR21","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12937-020-00582-4","volume":"19","author":"T Yuan","year":"2020","unstructured":"Yuan T, Si S, Li Y, Li W, Chen X, Liu C, et al. Roles for circulating polyunsaturated fatty acids in ischemic stroke and modifiable factors: a Mendelian randomization study. Nutr J. 2020;19(1):70.","journal-title":"Nutr J"},{"issue":"12","key":"2399_CR22","doi-asserted-by":"publisher","first-page":"3001","DOI":"10.3390\/nu11123001","volume":"11","author":"S Yuan","year":"2019","unstructured":"Yuan S, B\u00e4ck M, Bruzelius M, Mason AM, Burgess S, Larsson S. Plasma phospholipid fatty acids, FADS1 and risk of 15 cardiovascular diseases: a Mendelian randomisation study. Nutrients. 2019;11(12):3001.","journal-title":"Nutrients."},{"key":"2399_CR23","doi-asserted-by":"publisher","first-page":"103189","DOI":"10.1016\/j.ebiom.2020.103189","volume":"63","author":"T Zhang","year":"2021","unstructured":"Zhang T, Zhao JV, Schooling CM. The associations of plasma phospholipid arachidonic acid with cardiovascular diseases: a Mendelian randomization study. EBioMedicine. 2021;63:103189.","journal-title":"EBioMedicine"},{"issue":"6","key":"2399_CR24","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1001\/jamacardio.2020.0246","volume":"5","author":"HY Chen","year":"2020","unstructured":"Chen HY, Cairns BJ, Small AM, Burr HA, Ambikkumar A, Martinsson A, et al. Association of FADS1\/2 locus variants and polyunsaturated fatty acids with aortic stenosis. JAMA Cardiol. 2020;5(6):694\u2013702.","journal-title":"JAMA Cardiol"},{"issue":"7","key":"2399_CR25","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.3390\/nu11071651","volume":"11","author":"S Yuan","year":"2019","unstructured":"Yuan S, Larsson SC. Plasma phospholipid fatty acids and risk of atrial fibrillation: a Mendelian randomization study. Nutrients. 2019;11(7):1651.","journal-title":"Nutrients."},{"issue":"3","key":"2399_CR26","doi-asserted-by":"publisher","first-page":"e1001779","DOI":"10.1371\/journal.pmed.1001779","volume":"12","author":"C Sudlow","year":"2015","unstructured":"Sudlow C, Gallacher J, Allen N, Beral V, Burton P, Danesh J, et al. UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 2015;12(3):e1001779.","journal-title":"PLoS Med"},{"issue":"224","key":"2399_CR27","doi-asserted-by":"publisher","first-page":"224ed224","DOI":"10.1126\/scitranslmed.3008601","volume":"6","author":"NE Allen","year":"2014","unstructured":"Allen NE, Sudlow C, Peakman T, Collins R, Biobank UK. UK biobank data: come and get it. Sci Transl Med. 2014;6(224):224ed224.","journal-title":"Sci Transl Med"},{"issue":"9822","key":"2399_CR28","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/S0140-6736(12)60404-8","volume":"379","author":"R Collins","year":"2012","unstructured":"Collins R. What makes UK Biobank special? Lancet. 2012;379(9822):1173\u20134.","journal-title":"Lancet"},{"key":"2399_CR29","volume-title":"UK Biobank Genetic Data: MRC-IEU Quality Control, version 2 - Datasets - data.bris. data.bris","author":"R Mitchell","year":"2018","unstructured":"Mitchell R, Hemani G, Dudding T, Corbin L, Harrison S, Paternoster L. UK Biobank Genetic Data: MRC-IEU Quality Control, version 2 - Datasets - data.bris. data.bris; 2018."},{"key":"2399_CR30","doi-asserted-by":"publisher","first-page":"e63033","DOI":"10.7554\/eLife.63033","volume":"10","author":"H Julkunen","year":"2021","unstructured":"Julkunen H, Cichonska A, Slagboom PE, Wurtz P. Nightingale Health UKBI: Metabolic biomarker profiling for identification of susceptibility to severe pneumonia and COVID-19 in the general population. Elife. 2021;10:e63033.","journal-title":"Elife"},{"issue":"1","key":"2399_CR31","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1161\/CIRCGENETICS.114.000216","volume":"8","author":"P Soininen","year":"2015","unstructured":"Soininen P, Kangas AJ, Wurtz P, Suna T, Ala-Korpela M. Quantitative serum nuclear magnetic resonance metabolomics in cardiovascular epidemiology and genetics. Circ Cardiovasc Genet. 2015;8(1):192\u2013206.","journal-title":"Circ Cardiovasc Genet"},{"issue":"9","key":"2399_CR32","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1039\/b910205a","volume":"134","author":"P Soininen","year":"2009","unstructured":"Soininen P, Kangas AJ, Wurtz P, Tukiainen T, Tynkkynen T, Laatikainen R, et al. High-throughput serum NMR metabonomics for cost-effective holistic studies on systemic metabolism. Analyst. 2009;134(9):1781\u20135.","journal-title":"Analyst"},{"issue":"9","key":"2399_CR33","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1093\/aje\/kwx016","volume":"186","author":"P W\u00fcrtz","year":"2017","unstructured":"W\u00fcrtz P, Kangas AJ, Soininen P, Lawlor DA, Davey Smith G, Ala-Korpela M. Quantitative serum nuclear magnetic resonance metabolomics in large-scale epidemiology: a primer on -Omic technologies. Am J Epidemiol. 2017;186(9):1084\u201396.","journal-title":"Am J Epidemiol."},{"issue":"10","key":"2399_CR34","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1038\/ng.3396","volume":"47","author":"M Nikpay","year":"2015","unstructured":"Nikpay M, Goel A, Won HH, Hall LM, Willenborg C, Kanoni S, et al. A comprehensive 1,000 Genomes-based genome-wide association meta-analysis of coronary artery disease. Nat Genet. 2015;47(10):1121\u201330.","journal-title":"Nat Genet"},{"issue":"4","key":"2399_CR35","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s41588-018-0058-3","volume":"50","author":"R Malik","year":"2018","unstructured":"Malik R, Chauhan G, Traylor M, Sargurupremraj M, Okada Y, Mishra A, et al. Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes. Nat Genet. 2018;50(4):524\u201337.","journal-title":"Nat Genet"},{"issue":"9","key":"2399_CR36","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1038\/s41588-018-0171-3","volume":"50","author":"JB Nielsen","year":"2018","unstructured":"Nielsen JB, Thorolfsdottir RB, Fritsche LG, Zhou W, Skov MW, Graham SE, et al. Biobank-driven genomic discovery yields new insight into atrial fibrillation biology. Nat Genet. 2018;50(9):1234\u20139.","journal-title":"Nat Genet"},{"issue":"2","key":"2399_CR37","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1161\/CIRCRESAHA.116.308765","volume":"120","author":"GT Jones","year":"2017","unstructured":"Jones GT, Tromp G, Kuivaniemi H, Gretarsdottir S, Baas AF, Giusti B, et al. Meta-analysis of genome-wide association studies for abdominal aortic aneurysm identifies four new disease-specific risk loci. Circ Res. 2017;120(2):341\u201353.","journal-title":"Circ Res"},{"issue":"1","key":"2399_CR38","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/s41467-019-13690-5","volume":"11","author":"S Shah","year":"2020","unstructured":"Shah S, Henry A, Roselli C, Lin H, Sveinbjornsson G, Fatemifar G, et al. Genome-wide association and Mendelian randomisation analysis provide insights into the pathogenesis of heart failure. Nat Commun. 2020;11(1):163.","journal-title":"Nat Commun"},{"key":"2399_CR39","unstructured":"CARDIoGRAMplusC4D 1000 Genomes-based GWAS summary data (2015) [http:\/\/www.cardiogramplusc4d.org\/data-downloads\/]"},{"key":"2399_CR40","unstructured":"MEGASTROKE GWAS summary data (2018) [http:\/\/www.megastroke.org\/]"},{"key":"2399_CR41","volume-title":"Heart Failure GWAS summary data","author":"HERMES","year":"2020","unstructured":"HERMES Heart Failure GWAS summary data (2020) [https:\/\/kp4cd.org\/datasets\/mi]"},{"key":"2399_CR42","unstructured":"Atrial Fibrillation GWAS summary data (2018) [http:\/\/csg.sph.umich.edu\/willer\/public\/afib2018\/]"},{"key":"2399_CR43","unstructured":"FinnGen. Documentation of R4 release [https:\/\/finngen.gitbook.io\/documentation\/]"},{"issue":"7","key":"2399_CR44","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1038\/s41588-018-0144-6","volume":"50","author":"PR Loh","year":"2018","unstructured":"Loh PR, Kichaev G, Gazal S, Schoech AP, Price AL. Mixed-model association for biobank-scale datasets. Nat Genet. 2018;50(7):906\u20138.","journal-title":"Nat Genet"},{"key":"2399_CR45","volume-title":"MRC IEU UK Biobank GWAS pipeline version 2","author":"REB Mitchell","year":"2019","unstructured":"Mitchell REB, Raistrick CA, Paternoster L, Hemani G, Gaunt TR. MRC IEU UK Biobank GWAS pipeline version 2; 2019."},{"issue":"3","key":"2399_CR46","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/ng.3190","volume":"47","author":"PR Loh","year":"2015","unstructured":"Loh PR, Tucker G, Bulik-Sullivan BK, Vilhjalmsson BJ, Finucane HK, Salem RM, et al. Efficient Bayesian mixed-model analysis increases association power in large cohorts. Nat Genet. 2015;47(3):284\u201390.","journal-title":"Nat Genet"},{"key":"2399_CR47","first-page":"2008.2010.24429","volume":"2020","author":"B Elsworth","year":"2020","unstructured":"Elsworth B, Lyon M, Alexander T, Liu Y, Matthews P, Hallett J, et al. The MRC IEU OpenGWAS data infrastructure. bioRxiv. 2020;2020:2008.2010.244293.","journal-title":"bioRxiv"},{"key":"2399_CR48","unstructured":"MRC Integrative Epidemiology Unit. IEU Open GWAS Project [https:\/\/gwas.mrcieu.ac.uk\/]"},{"issue":"3","key":"2399_CR49","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/ng.3211","volume":"47","author":"BK Bulik-Sullivan","year":"2015","unstructured":"Bulik-Sullivan BK, Loh PR, Finucane HK, Ripke S, Yang J, Schizophrenia Working Group of the Psychiatric Genomics C, et al. LD Score regression distinguishes confounding from polygenicity in genome-wide association studies. Nat Genet. 2015;47(3):291\u20135.","journal-title":"Nat Genet"},{"issue":"11","key":"2399_CR50","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1038\/ng.3406","volume":"47","author":"B Bulik-Sullivan","year":"2015","unstructured":"Bulik-Sullivan B, Finucane HK, Anttila V, Gusev A, Day FR, Loh PR, et al. An atlas of genetic correlations across human diseases and traits. Nat Genet. 2015;47(11):1236\u201341.","journal-title":"Nat Genet"},{"issue":"1","key":"2399_CR51","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1038\/s41467-017-01261-5","volume":"8","author":"K Watanabe","year":"2017","unstructured":"Watanabe K, Taskesen E, van Bochoven A, Posthuma D. Functional mapping and annotation of genetic associations with FUMA. Nat Commun. 2017;8(1):1826.","journal-title":"Nat Commun"},{"issue":"16","key":"2399_CR52","doi-asserted-by":"publisher","first-page":"e164","DOI":"10.1093\/nar\/gkq603","volume":"38","author":"K Wang","year":"2010","unstructured":"Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 2010;38(16):e164.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"2399_CR53","doi-asserted-by":"publisher","first-page":"D1005","DOI":"10.1093\/nar\/gky1120","volume":"47","author":"A Buniello","year":"2019","unstructured":"Buniello A, MacArthur JAL, Cerezo M, Harris LW, Hayhurst J, Malangone C, et al. The NHGRI-EBI GWAS Catalog of published genome-wide association studies, targeted arrays and summary statistics 2019. Nucleic Acids Res. 2019;47(D1):D1005\u201312.","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"2399_CR54","doi-asserted-by":"publisher","first-page":"e1004219","DOI":"10.1371\/journal.pcbi.1004219","volume":"11","author":"CA de Leeuw","year":"2015","unstructured":"de Leeuw CA, Mooij JM, Heskes T, Posthuma D. MAGMA: generalized gene-set analysis of GWAS data. PLoS Comput Biol. 2015;11(4):e1004219.","journal-title":"PLoS Comput Biol"},{"issue":"6","key":"2399_CR55","first-page":"1961","volume":"45","author":"J Bowden","year":"2016","unstructured":"Bowden J, Del Greco MF, Minelli C, Davey Smith G, Sheehan NA, Thompson JR. Assessing the suitability of summary data for two-sample Mendelian randomization analyses using MR-Egger regression: the role of the I2 statistic. Int J Epidemiol. 2016;45(6):1961\u201374.","journal-title":"Int J Epidemiol."},{"issue":"7","key":"2399_CR56","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1002\/gepi.21998","volume":"40","author":"S Burgess","year":"2016","unstructured":"Burgess S, Davies NM, Thompson SG. Bias due to participant overlap in two-sample Mendelian randomization. Genet Epidemiol. 2016;40(7):597\u2013608.","journal-title":"Genet Epidemiol"},{"issue":"2","key":"2399_CR57","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/ije\/dyv080","volume":"44","author":"J Bowden","year":"2015","unstructured":"Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol. 2015;44(2):512\u201325.","journal-title":"Int J Epidemiol"},{"issue":"11","key":"2399_CR58","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1002\/sim.7221","volume":"36","author":"J Bowden","year":"2017","unstructured":"Bowden J, Del Greco MF, Minelli C, Davey Smith G, Sheehan N, Thompson J. A framework for the investigation of pleiotropy in two-sample summary data Mendelian randomization. Stat Med. 2017;36(11):1783\u2013802.","journal-title":"Stat Med"},{"issue":"3","key":"2399_CR59","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1093\/ije\/dyy262","volume":"48","author":"E Sanderson","year":"2019","unstructured":"Sanderson E, Davey Smith G, Windmeijer F, Bowden J. An examination of multivariable Mendelian randomization in the single-sample and two-sample summary data settings. Int J Epidemiol. 2019;48(3):713\u201327.","journal-title":"Int J Epidemiol."},{"key":"2399_CR60","doi-asserted-by":"publisher","first-page":"e34408","DOI":"10.7554\/eLife.34408","volume":"7","author":"G Hemani","year":"2018","unstructured":"Hemani G, Zheng J, Elsworth B, Wade KH, Haberland V, Baird D, et al. The MR-Base platform supports systematic causal inference across the human phenome. Elife. 2018;7:e34408.","journal-title":"Elife"},{"issue":"5","key":"2399_CR61","doi-asserted-by":"publisher","first-page":"e013131","DOI":"10.1161\/JAHA.119.013131","volume":"9","author":"MC Borges","year":"2020","unstructured":"Borges MC, Schmidt AF, Jefferis B, Wannamethee SG, Lawlor DA, Kivimaki M, et al. Circulating fatty acids and risk of coronary heart disease and stroke: individual participant data meta-analysis in up to 16 126 participants. J Am Heart Assoc. 2020;9(5):e013131.","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"2399_CR62","doi-asserted-by":"publisher","first-page":"398","DOI":"10.7326\/M13-1788","volume":"160","author":"R Chowdhury","year":"2014","unstructured":"Chowdhury R, Warnakula S, Kunutsor S, Crowe F, Ward HA, Johnson L, et al. Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysis. Ann Intern Med. 2014;160(6):398\u2013406.","journal-title":"Ann Intern Med"},{"key":"2399_CR63","doi-asserted-by":"publisher","first-page":"e6698","DOI":"10.1136\/bmj.e6698","volume":"345","author":"R Chowdhury","year":"2012","unstructured":"Chowdhury R, Stevens S, Gorman D, Pan A, Warnakula S, Chowdhury S, et al. Association between fish consumption, long chain omega 3 fatty acids, and risk of cerebrovascular disease: systematic review and meta-analysis. BMJ. 2012;345:e6698.","journal-title":"BMJ"},{"issue":"8","key":"2399_CR64","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1161\/01.STR.0000023890.25066.50","volume":"33","author":"H Iso","year":"2002","unstructured":"Iso H, Sato S, Umemura U, Kudo M, Koike K, Kitamura A, et al. Linoleic acid, other fatty acids, and the risk of stroke. Stroke. 2002;33(8):2086\u201393.","journal-title":"Stroke"},{"issue":"1","key":"2399_CR65","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1812792","volume":"380","author":"DL Bhatt","year":"2019","unstructured":"Bhatt DL, Steg PG, Miller M, Brinton EA, Jacobson TA, Ketchum SB, et al. Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia. N Engl J Med. 2019;380(1):11\u201322.","journal-title":"N Engl J Med"},{"issue":"1","key":"2399_CR66","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1056\/NEJMoa1811403","volume":"380","author":"JE Manson","year":"2019","unstructured":"Manson JE, Cook NR, Lee IM, Christen W, Bassuk SS, Mora S, et al. Marine n-3 fatty acids and prevention of cardiovascular disease and cancer. N Engl J Med. 2019;380(1):23\u201332.","journal-title":"N Engl J Med"},{"issue":"22","key":"2399_CR67","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1001\/jama.2020.22258","volume":"324","author":"SJ Nicholls","year":"2020","unstructured":"Nicholls SJ, Lincoff AM, Garcia M, Bash D, Ballantyne CM, Barter PJ, et al. Effect of high-dose omega-3 fatty acids vs corn oil on major adverse cardiovascular events in patients at high cardiovascular risk: the STRENGTH randomized clinical trial. JAMA. 2020;324(22):2268\u201380.","journal-title":"JAMA"},{"issue":"10","key":"2399_CR68","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1001\/jama.2017.11467","volume":"318","author":"BA Ference","year":"2017","unstructured":"Ference BA, Kastelein JJP, Ginsberg HN, Chapman MJ, Nicholls SJ, Ray KK, et al. Association of genetic variants related to CETP inhibitors and statins with lipoprotein levels and cardiovascular risk. JAMA. 2017;318(10):947\u201356.","journal-title":"JAMA"},{"issue":"22","key":"2399_CR69","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1056\/NEJMoa1604304","volume":"375","author":"BA Ference","year":"2016","unstructured":"Ference BA, Robinson JG, Brook RD, Catapano AL, Chapman MJ, Neff DR, et al. Variation in PCSK9 and HMGCR and risk of cardiovascular disease and diabetes. N Engl J Med. 2016;375(22):2144\u201353.","journal-title":"N Engl J Med"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-022-02399-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-022-02399-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-022-02399-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T00:02:46Z","timestamp":1655078566000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-022-02399-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,13]]},"references-count":69,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2399"],"URL":"https:\/\/doi.org\/10.1186\/s12916-022-02399-w","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,13]]},"assertion":[{"value":"29 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The UK Biobank received ethical approval from the Research Ethics Committee (REC reference for the UK Biobank is 11\/NW\/0382).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"DAL is an Editorial Advisor for BMC Medicine and acknowledges support from Roche Diagnostics and Medtronic Ltd for research unrelated to that presented here. All other authors declare they have no conflict of interest, financial or otherwise.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"210"}}